Monitor for any escalation in similar slip-and-fall litigation against CVS, though this single case poses minimal financial risk. The narrow reversal on technical grounds does not suggest systemic issues, but could encourage copycat claims. Watch for how the district court handles the Daubert challenge on remand, which could still eliminate the expert testimony.
Price Chart
Executive Summary
The D.C. Circuit Court of Appeals reversed a lower court's summary judgment in favor of CVS Pharmacy in a slip-and-fall case, finding that the plaintiffs presented sufficient expert evidence to create a genuine issue of material fact about whether the walkway was dangerously slippery. The ruling allows the negligence claim to proceed to trial, while upholding dismissal of the negligence per se claim. This is a minor adverse development for CVS, increasing litigation risk but not resulting in immediate financial liability.
Court Ruling Details
Key Facts
- D.C. Circuit reversed district court's grant of summary judgment to CVS in a slip-and-fall case involving plaintiff Bruce Bunting
- Plaintiffs' expert testimony created a genuine issue of material fact regarding whether the walkway's coefficient of friction (COF) fell below the 0.50 safety standard
- CVS's own expert recorded a COF of 0.49 on the wet walkway near where Bunting fell
- Appellate court affirmed dismissal of the negligence per se claim based on D.C. municipal regulations
- Case remanded for further proceedings, including potential Daubert challenges to expert testimony
- One appellate judge expressed strong skepticism about the reliability of the plaintiffs' expert methodology
Financial Impact
Exposure limited to personal injury damages from a single incident; likely under $10M and less than 0.01% of CVS's $98.1B market cap
Risk Factors
- Potential for increased slip-and-fall litigation if plaintiffs perceive CVS as vulnerable
- Reputational risk from adverse appellate ruling, despite limited financial exposure
- Uncertainty around admissibility of expert testimony on remand
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-1x1sosp9-CVS |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 8w ago | 8-K | $99.12 $97.23 | ▼ −1.91% | ▼ −1.31% | $85.20 (−14.04%) |
Jul 10, 2026 11w ago | Press Release | $104.15 $95.46 | ▼ −8.35% | ▼ −10.77% | $85.20 (−18.19%) |
Jun 29, 2026 13w ago | Court Ruling | $103.58 $107.74 | ▲ +4.02% | ▲ +4.30% | $85.20 (−17.74%) |
May 22, 2026 18w ago | S-3ASR | $90.55 $101.57 | ▲ +12.17% | ▲ +14.44% | $85.20 (−5.91%) |
May 19, 2026 19w ago | Court Ruling | $93.11 $99.16 | ▲ +6.50% | ▲ +6.54% | $85.20 (−8.49%) |
May 15, 2026 20w ago | Court Ruling | $95.88 $100.68 | ▲ +5.01% | ▲ +2.89% | $85.20 (−11.14%) |
May 6, 2026 21w ago | 8-K | $86.76 $91.37 | ▲ +5.32% | ▲ +2.54% | $85.20 (−1.79%) |
May 4, 2026 21w ago | Court Ruling | $82.01 $89.50 | ▲ +9.13% | ▲ +3.34% | $85.20 (+3.89%) |
Apr 29, 2026 22w ago | Court Ruling | $83.84 $92.97 | ▲ +10.89% | ▲ +4.85% | $85.20 (+1.62%) |
Apr 14, 2026 24w ago | Court Ruling | $77.60 $92.22 | ▼ −18.85% | ▼ −12.55% | $85.20 (−9.80%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access